Michael J. McElhaugh, Chief Business Officer at Arbutus Biopharma Corp (ABUS), sold 40,000 shares at $5.00 ($200K) on 2020-12-14, disclosed to the SEC on 2020-12-16.
Open-market sale of $200k ABUS by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 10,000 | $50K | 25.0% |
| 2 | $5.00 | 30,000 | $150K | 75.0% |
| Total | $5.00 avg | 40,000 | $200K | 100% |
| Filing → |
| ABUS | SELL | 2021-02-10 | $100K | — | Filing → |
| ABUS | SELL | 2020-07-27 | $100K | — | Filing → |